BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 33994540)

  • 1. Involvement of cancer-derived EMT cells in the accumulation of
    Sugita S; Yamato M; Hatabu T; Kataoka Y
    Sci Rep; 2021 May; 11(1):9668. PubMed ID: 33994540
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The reverse Warburg effect and 18F-FDG uptake in non-small cell lung cancer A549 in mice: a pilot study.
    Zhang G; Li J; Wang X; Ma Y; Yin X; Wang F; Zheng H; Duan X; Postel GC; Li XF
    J Nucl Med; 2015 Apr; 56(4):607-12. PubMed ID: 25722447
    [TBL] [Abstract][Full Text] [Related]  

  • 3.
    Mitchell KG; Amini B; Wang Y; Carter BW; Godoy MCB; Parra ER; Behrens C; Villalobos P; Reuben A; Lee JJ; Weissferdt A; Moran CA; Fujimoto J; Sepesi B; Walsh GL; Vaporciyan AA; Hofstetter WL; William WN; Gibbons DL; Wang J; Hwu P; Swisher SG; Piwnica-Worms D; Kadara H; Wistuba II; Heymach JV; Peng W; Cascone T
    Cancer Immunol Immunother; 2020 Aug; 69(8):1519-1534. PubMed ID: 32300858
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 18F-Fluorodeoxyglucose uptake on positron emission tomography/computed tomography is associated with metastasis and epithelial-mesenchymal transition in hepatocellular carcinoma.
    Lee M; Jeon JY; Neugent ML; Kim JW; Yun M
    Clin Exp Metastasis; 2017 Apr; 34(3-4):251-260. PubMed ID: 28429188
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor microenvironment-dependent 18F-FDG, 18F-fluorothymidine, and 18F-misonidazole uptake: a pilot study in mouse models of human non-small cell lung cancer.
    Huang T; Civelek AC; Li J; Jiang H; Ng CK; Postel GC; Shen B; Li XF
    J Nucl Med; 2012 Aug; 53(8):1262-8. PubMed ID: 22717978
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and Bioevaluation of Novel [
    Yang X; Wang F; Zhu H; Yang Z; Chu T
    Mol Pharm; 2019 May; 16(5):2118-2128. PubMed ID: 30964298
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypoxia and glucose metabolism in malignant tumors: evaluation by [18F]fluoromisonidazole and [18F]fluorodeoxyglucose positron emission tomography imaging.
    Rajendran JG; Mankoff DA; O'Sullivan F; Peterson LM; Schwartz DL; Conrad EU; Spence AM; Muzi M; Farwell DG; Krohn KA
    Clin Cancer Res; 2004 Apr; 10(7):2245-52. PubMed ID: 15073099
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Revisit 18F-fluorodeoxyglucose oncology positron emission tomography: "systems molecular imaging" of glucose metabolism.
    Shen B; Huang T; Sun Y; Jin Z; Li XF
    Oncotarget; 2017 Jun; 8(26):43536-43542. PubMed ID: 28402949
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cellular uptake of PET tracers of glucose metabolism and hypoxia and their linkage.
    Busk M; Horsman MR; Jakobsen S; Bussink J; van der Kogel A; Overgaard J
    Eur J Nucl Med Mol Imaging; 2008 Dec; 35(12):2294-303. PubMed ID: 18682937
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New insight on the correlation of metabolic status on
    Wang Y; Zhao N; Wu Z; Pan N; Shen X; Liu T; Wei F; You J; Xu W; Ren X
    Eur J Nucl Med Mol Imaging; 2020 May; 47(5):1127-1136. PubMed ID: 31502013
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aerobic glycolysis in cancers: implications for the usability of oxygen-responsive genes and fluorodeoxyglucose-PET as markers of tissue hypoxia.
    Busk M; Horsman MR; Kristjansen PE; van der Kogel AJ; Bussink J; Overgaard J
    Int J Cancer; 2008 Jun; 122(12):2726-34. PubMed ID: 18351643
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Evolving Role of Succinate in Tumor Metabolism: An
    Garrigue P; Bodin-Hullin A; Balasse L; Fernandez S; Essamet W; Dignat-George F; Pacak K; Guillet B; Taïeb D
    J Nucl Med; 2017 Nov; 58(11):1749-1755. PubMed ID: 28619735
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cancer-associated fibroblasts enhance tumor
    Shangguan C; Gan G; Zhang J; Wu J; Miao Y; Zhang M; Li B; Mi J
    Theranostics; 2018; 8(5):1376-1388. PubMed ID: 29507627
    [No Abstract]   [Full Text] [Related]  

  • 14. The correlation of
    Qu YH; Long N; Ran C; Sun J
    Clin Transl Oncol; 2021 Mar; 23(3):620-627. PubMed ID: 32683540
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of 18F-FDG accumulation in colorectal cancer cells with mutated KRAS.
    Iwamoto M; Kawada K; Nakamoto Y; Itatani Y; Inamoto S; Toda K; Kimura H; Sasazuki T; Shirasawa S; Okuyama H; Inoue M; Hasegawa S; Togashi K; Sakai Y
    J Nucl Med; 2014 Dec; 55(12):2038-44. PubMed ID: 25453050
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is (18)F-FDG a surrogate tracer to measure tumor hypoxia? Comparison with the hypoxic tracer (14)C-EF3 in animal tumor models.
    Christian N; Deheneffe S; Bol A; De Bast M; Labar D; Lee JA; Grégoire V
    Radiother Oncol; 2010 Nov; 97(2):183-8. PubMed ID: 20304513
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Effect of Carbogen Breathing on
    Lin Y; Bao YN; Huang CX; Zhang JH; Yu ZL; Tian Y; Wang XC; Cui YT
    Biomed Res Int; 2019; 2019():2920169. PubMed ID: 31886195
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of PPAR-gamma agonist on (18)F-FDG uptake in tumor and macrophages and tumor cells.
    Kim SL; Kim EM; Cheong SJ; Lee CM; Kim DW; Jeong HJ; Lim ST; Sohn MH; Yim CY
    Nucl Med Biol; 2009 May; 36(4):427-33. PubMed ID: 19423011
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of PPAR-γ agonist on (18)F-FDG PET imaging for differentiating tumors and inflammation lesions.
    Cheong SJ; Lee CM; Kim EM; Lim ST; Sohn MH; Jeong HJ
    Nucl Med Biol; 2015 Feb; 42(2):85-91. PubMed ID: 25441255
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immune microenvironment of the gene signature reflecting the standardised uptake value on
    Han S; Oh JS; Kim JS
    Ann Nucl Med; 2021 Jan; 35(1):65-75. PubMed ID: 33044632
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.